Hypertension: all 6,834 studies

Page 63 of 69. Open to participants first (971), then studies with results posted, then the rest; newest registration first within each.

• Valsartan Optimal Therapy Against Elevated Home Blood Pressure Research（VOYAGER）StudyCompletedNCT00460213Phase 4
• Sleep Apnea and Refractory Hypertension: Prevalence and Effect of CPAP TreatmentCompletedNCT00459914Phase 2
• Effect of Electrical Stimulation at Acupoints on Blood PressureCompletedNCT00459758Phase 1
• Acupuncture and Laser Acupoint Treatment on HypertensionStatus unknownNCT00459680Phase 1
• Vitamin D and Blood PressureWithdrawnNCT00459563Not applicable
• The Effect of Frequent Self Measurements of Blood Pressure on the Control of HypertensionCompletedNCT00459017Phase 3
• Study of the Efficacy and Safety of Tezosentan in Patients With Pre-operative Pulmonary Hypertension, Due to Left Heart Disease, Undergoing Open Heart SurgeryTerminatedNCT00458276Phase 3
• Transitioning To IV Remodulin From Ventavis in Patients With PAH: Safety, Efficacy and Treatment SatisfactionTerminatedNCT00458042Phase 4
• Nijmegen Antihypertensive Management Improvement StudyCompletedNCT00457483Phase 4
• Prevention of Diabetes and HypertensionTerminatedNCT00456963Phase 4
• Combination of OLMesartan and CCB or Low Dose Diuretics in High Risk Elderly Hypertensive Patients Study (COLM-Study)CompletedNCT00454662Phase 4
• An Open Multiple Dose Titration Study In Patients With Pulmonary HypertensionCompletedNCT00454558Phase 2
• Safety and Efficacy of Inhaled Iloprost in Pediatric Patients With Pulmonary Arterial HypertensionWithdrawnNCT00453414Phase 2
• Effects of a Structured Education Program on Blood Pressure in Essential Hypertensive PatientsCompletedNCT00453037Not applicable
• Changes in Eye Pressure and Anterior Chamber Depth With Oral Endothelin Antagonist TherapyCompletedNCT00452283
• Sorafenib Study: Dosing in Patients With Pulmonary Arterial Hypertension (PAH)CompletedNCT00452218Phase 1
• The Therapeutic Effect of Bromocriptin in Patients With Primary AldosteronismStatus unknownNCT00451672Phase 4
• Secondary Prophylaxis After Variceal Bleeding in Non-RespondersCompletedNCT00450164Phase 4
• Comparison of Awakening Versus Bedtime Dosing of Aspirin in Pre-Hypertension or Mild Essential HypertensionTerminatedNCT00449618Phase 4
• An Open Label Study to Assess the Efficacy, Safety and Tolerability of COZAAR Plus (Losartan Potassium 50mg/Hydrochlorothiazide 12.5mg) Possibly Titrated up to COZAAR Plus-F (Losartan Potassium 100mg/Hydrochlorothiazide 25mg) in Patients With Essential Hypertension (0954A-325)TerminatedNCT00449111Phase 3
• Nitrate and Hypertension in Heart Transplanted PatientsCompletedNCT00449059Phase 4
• The Chinese Mutation Hotspot of ENaC Causing Liddle's Syndrome and the Association of ENaC Variations and HypertensionSuspendedNCT00448162
• High Blood Pressure Strategy (HBPS)Status unknownNCT00446914Not applicable
• Long Term Study of Valsartan and Amlodipine in Patients With Essential Hypertension (Extension to Study CVAA489A1301)CompletedNCT00446524Phase 3
• A Study of Controlled-Release Carvedilol Compared to Immediate-Release Carvedilol in Patients With Primary HypertensionTerminatedNCT00444834Phase 2
• SPHERE Hypertension Baseline Data StudyCompletedNCT00444496
• Study of INS115644 Ophthalmic Solution in Subjects With Ocular Hypertension or GlaucomaCompletedNCT00443924Phase 1
• N-Terminal Pro-brain Natriuretic Peptide Hormone and Persistent Pulmonary HypertensionTerminatedNCT00443859
• Irbesartan/Hydrochlorothiazide National Taiwan University Hospital ListingCompletedNCT00443612Phase 4
• Veteran Preference For Group Visits and Its Effect on Hypertension OutcomesCompletedNCT00439816Not applicable
• Trial of Iloprost in Pulmonary Hypertension Secondary to Pulmonary FibrosisStatus unknownNCT00439543Phase 2/3
• The Effect of Eprosartan on Hormones and Kidney Function in Patients With Essential HypertensionCompletedNCT00438945Phase 4
• Effect of Ketamine (Ketalar) on Intracranial PressureStatus unknownNCT00437814Not applicable
• 6R-BH4 Pulmonary Arterial Hypertension StudyCompletedNCT00435331Phase 1
• Evaluation of the Prevalence of Pulmonary Hypertension in Adult Patients With Sickle Cell DiseaseStatus unknownNCT00434902
• A Nutrition Intervention to Lower Blood Pressure in AdolescentsCompletedNCT00431288Not applicable
• The Efficacy of Spironolactone in Patients With Resistant HypertensionTerminatedNCT00430794Phase 2
• Double Blind Crossover Comparison of Diuretics in the YoungStatus unknownNCT00429897Not applicable
• Safety and Efficacy of Valsartan Plus Hydrochlorothiazide and Amlodipine in Hypertensive PatientsCompletedNCT00426478Phase 4
• Efficacy of Valsartan/Hydrochlorothiazide Versus Amlodipine and Hydrochlorothiazide in Patients HypertensionCompletedNCT00425997Phase 4
• Pharmacokinetic and Pharmacodynamic Profiles of Aliskiren in Japanese Patients With Mild to Moderate Essential HypertensionCompletedNCT00424541Phase 1
• Study to Assess Safety and Efficacy of Ambrisentan in Subjects With Pulmonary Arterial Hypertension.CompletedNCT00423748Phase 3
• A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Assess Safety and Efficacy of Ambrisentan in Subjects With Pulmonary Arterial Hypertension.CompletedNCT00423202Phase 3
• The Metabolic Effects of Different Weight Loss DietsCompletedNCT00422630Not applicable
• Italian Study on the Cardiovascular Effects of Systolic Blood Pressure Control - CARDIOSIS StudyCompletedNCT00421863Phase 4
• Effects of Cocoa Intake on Blood Pressure in Elderly Individuals With Mild HypertensionCompletedNCT00421499Phase 1
• The Effect of Daily Intakes of Dairy Products on Blood Pressure in Human BeingsCompletedNCT00420446Not applicable
• Effects of Lumiracoxib and Ibuprofen on Blood Pressure and Urinary Eicosanoid Excretion in Osteoarthritis Patients With Controlled HypertensionCompletedNCT00419796Phase 4
• IMPlementation of gUideLines for the Management of Arterial hypertenSION. The IMPULSION StudyCompletedNCT00416611
• Efficacy of Rostafuroxin in the Treatment of Essential HypertensionCompletedNCT00415038Phase 2
• Preliminary Efficacy and Tolerability of NCX-1000 After Repeated Oral Doses in Patients With Elevated Portal PressureTerminatedNCT00414869Phase 2
• Transfusion Requirements in Gastrointestinal (GI) BleedingStatus unknownNCT00414713Phase 4
• Aerosolized Randomized Iloprost Study II (AIR - II) Long-Term Safety, Tolerability, and Clinical Effects of Iloprost Inhalation in Patients With Primary or Secondary Pulmonary HypertensionCompletedNCT00414687Phase 2
• Insulin Resistance and Hypertensive Disorders in PregnancyCompletedNCT00412230
• One Year Study to Evaluate the Safety of the Combination of Valsartan and Amlodipine in Patients With HypertensionCompletedNCT00409851Phase 3
• Safety and Efficacy of Valsartan and Amlodipine Combined and Alone in Patients With Hypertension.CompletedNCT00409760Phase 3
• Safety and Efficacy of Valsartan and Amlodipine Combined and Alone in Hypertensive PatientsCompletedNCT00409643Phase 3
• Inhaled Iloprost for the Treatment of Persistent Pulmonary Hypertension in the Term and Near Term Infants.TerminatedNCT00409526Phase 4
• Effects of Continuous Positive Airway Pressure and Valsartan Treatments on Arterial Blood Pressure in OSAS PatientsCompletedNCT00409487Phase 4
• Treatment of Severe Hypertension During Pre-Eclampsia: A Preliminary Equivalence Study Between Urapidil and NicardipineStatus unknownNCT00409253Phase 3
• The Effect of a Complementary Multi Disciplinary Program on Blood Pressure in Hypertensive PatientsCompletedNCT00409149Phase 3
• Pharmacosurveillance and Pharmacogenetics of First-line Diuretics in Hypertension: The StayOnDiur StudyCompletedNCT00408512Phase 4
• Diagnostic Properties of Aldosterone-Renin Ratio in Primary Aldosteronism Among Hypertensives.Status unknownNCT00407784
• Intensive Medical Treatment for Nephropathy Caused by Type 2 Diabetes With HypertensionStatus unknownNCT00407680Phase 4
• Health Literacy-Focused Program to Improve Blood Pressure Control in Korean AmericansCompletedNCT00406614Not applicable
• Oxidative Stress Lowering Effect of Simvastatin and Atorvastatin.Status unknownNCT00404599Phase 4
• Patient and Provider Attitudes in the Healthcare ContextCompletedNCT00404027
• Inhaled Iloprost for Sarcoidosis-associated Pulmonary HypertensionCompletedNCT00403650Phase 4
• Study to Determine if Taking OTC Non-Steroidal Anti-Inflammatory Affects Eye Pressure in Patients Using Glaucoma DropsCompletedNCT00402493Not applicable
• Efficacy and Safety of Valsartan, Hydrochlorothiazide and Amlodipine Combination Therapy in HypertensionCompletedNCT00400777Phase 4
• Evaluate the Safety and Anti-Hypertensive Efficacy of Hyzaar(R) In Patients With Mild To Moderate Essential Hypertension (0954A-323)CompletedNCT00400218Phase 3
• Impact of a Computerized Guidelines on the Management of Hypertension and DiabetesCompletedNCT00398944Not applicable
• Evaluation of the Antihypertensive Effect of Hyzaar(R) and Cognitive Function of Hypertensive Patients (0954A-322)CompletedNCT00398541Phase 3
• VALIDATE Valsartan and Supportive Measures - Impact on Drug Adherence of Treated Hypertensive PatientsCompletedNCT00394823Phase 3
• Effect of Valsartan on Lipid Subfractions in Hypertensive Patients With Metabolic SyndromeCompletedNCT00394745Phase 3
• Antihypertensive Effectiveness of the Associations of Hydrochlorothiazide and Amiloride and Hydrochlorothiazide and EnalaprilCompletedNCT00394394Phase 2
• Federal Study of Adherence to Medications in the Elderly (FAME)CompletedNCT00393419Not applicable
• A Study to Evaluate the Combination of Valsartan + Amlodipine in Hypertensive PatientsCompletedNCT00392262Phase 3
• DORADO-AC - Optimized Doses of Darusentan as Compared to an Active Control in Resistant HypertensionCompletedNCT00389779Phase 3
• DORADO-AC-EX - A Long-Term Safety Extension Study to the Phase 3 DORADOC-AC Study (Protocol DAR-312) of Darusentan in Resistant HypertensionTerminatedNCT00389675Phase 3
• Renal Artery Calcium and HypertensionStatus unknownNCT00388869
• Improving Medication Use in Patients With HypertensionCompletedNCT00388817Not applicable
• Safety/Efficacy of Combo Therapy With Aliskiren & Hydrochlorothiazide vs Therapy With Hydrochlorothiazide Alone in Patients With HypertensionCompletedNCT00387517Phase 3
• Administration Time-dependent Antihypertensive Effects of Low Dose Aspirin in Well-controlled Hypertensive PatientsCompletedNCT00386529Phase 4
• A Safety and Efficacy Trial of the Combination of Aliskiren / Hydrochlorothiazide (HCTZ)(300/12.5 mg and 300/25 mg) Compared to Aliskiren 300 mg in Hypertensive PatientsCompletedNCT00386139Phase 3
• Efficacy and Safety of Valsartan and the Combination of Valsartan and SimvastatinCompletedNCT00385931Phase 3
• Antihypertensive Efficacy and Safety of Candesartan/HCT 32/12.5 and 32/25 mg in Comparison With Candesartan 32 mgCompletedNCT00383929Phase 3
• Magnetic Resonance Angiography to Diagnose Atherosclerotic DiseaseCompletedNCT00382564
• Risk Assessment of Long-Haul Truck DriversCompletedNCT00381992
• Early Metabolic Changes With Thiazide or Beta Blocker Therapy for Essential HypertensionStatus unknownNCT00380289Not applicable
• Community Partnership to Examine Racial and Ethnic Differences in Health Care for Hypertension and DiabetesCompletedNCT00379652Not applicable
• Multi-center, Web Based Observational Study of Pulmonary Hypertension in Scleroderma PatientsCompletedNCT00377949
• Individually Tailored Web-Based Program to Improve Blood Pressure ControlCompletedNCT00377208Not applicable
• Phase IIa Safety and Efficacy Study of SPP635 in Mild to Moderate HypertensionCompletedNCT00376636Phase 2
• A Study in People With Mild HypertensionCompletedNCT00374855Phase 2
• Impact of an IT-Based and Healthcare Professional Support Program on Patients With High Blood PressureStatus unknownNCT00374829Not applicable
• A Phase II Study of AL-37807 to Treat Open-Angle Glaucoma or Ocular HypertensionCompletedNCT00372931Phase 2
• Study of Brinzolamide and Timolol When Added to Travoprost in Primary Open-angle Glaucoma or Ocular HypertensionCompletedNCT00372827Phase 4
• Safety and Efficacy Study of Transplantation of EPCs to Treat Idiopathic Pulmonary Arterial HypertensionStatus unknownNCT00372346Not applicable
• REVEAL Registry™: Registry to Evaluate Early And Long-term PAH Disease ManagementCompletedNCT00370214

← Hypertension overview